Mobile

A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metfo...

Mise à jour : Il y a 4 ans
Référence : EUCTR2006-001392-37

A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of the Addition of Sitagliptin to Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Monotherapy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Main objective : After 18 weeks, to assess the effect of the addition of treatment with sitagliptin compared to placebo on HbAıc.

Critère d'inclusion

  • Type 2 diabetes mellitus

Liens